Product Reports Resources Pricing Login Book a demo

Praxis Precision Medicines

Biotech & Life Sciences · Cambridge, United States · Founded 2015 · IPO 2020

Praxis Precision Medicines is a clinical stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, particularly those characterized by neuronal imbalance. The company leverages insights from genetic epilepsies to create innovative treatments aimed at addressing unmet medical needs. Praxis operates in the biopharmaceutical market, primarily serving patients with CNS disorders and their caregivers. The business model revolves around patient-guided development strategies, ensuring that the therapies developed are aligned with what patients actually need. Revenue is generated through the development and potential commercialization of these therapies, as well as through partnerships and collaborations with other entities in the healthcare sector. Keywords: CNS disorders, genetic epilepsies, biopharmaceutical, therapies, neuronal imbalance, patient-guided, clinical stage, innovation, healthcare, partnerships.

Valuation $7.80B
Revenue $2.3M
Total funding $100–500M
Power Law Unicorn$1–10B valuation tier

Investors

14 investors on Praxis Precision Medicines's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 14 investors entered at this stage
Eventide Asset Management
Qatar Investment Authority
Point72 Ventures
Citadel
Blackstone
Adage Capital
Novo Holdings
Cormorant Asset Management
Vida Ventures
Irving Investors
OCV Partners
Avoro Capital Advisors
Verition Fund Management
Affinity Asset Advisors

Global footprint

Where Praxis Precision Medicines has talent and traffic

Workforce by country
5 countries with
team presence
🇺🇸 United States97%
🇦🇺 Australia1.2%
🇧🇷 Brazil0.6%
🇮🇳 India0.6%
🇨🇴 Colombia0.6%
5 countries shown
Web traffic by country
11K monthly visits
across markets
🇺🇸 United States71.8%
🇨🇦 Canada16.4%
🇮🇳 India9.1%
🇧🇷 Brazil3.6%
🇮🇹 Italy0.9%
Top 5 markets shown

Talent graph

The shape of Praxis Precision Medicines's talent

Dealroom maps Praxis Precision Medicines's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

11 team members profilednamed & role-tagged by Dealroom
252 employeestotal headcount
5 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Praxis Precision Medicines's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$36M patent portfolio · 49 active families

Estimated portfolio value
$36M
0.46% of market cap · 5.3× smaller than top peer Moderna Therapeutics ($189M)
49 active patent families
Where Praxis Precision Medicines innovates BiochemistryCalcium channelDepressantDiseaseDravet syndrome

Where Praxis Precision Medicines concentrates vs peers

Each axis is a top-10 topic across Praxis Precision Medicines and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Praxis Precision Medicines

An AI-synthesized read of the highest-engagement posts about Praxis Precision Medicines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Praxis Precision Medicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles